Why Your PCOS Patients Keep Asking About Keto—And What the Science Actually Says
A physician’s guide to the latest evidence on ketogenic diets for polycystic ovary syndrome
“Doctor, I saw on Instagram that keto cured someone’s PCOS. Should I try it?”
If you’re an OB/GYN or women’s health provider, you’ve heard this question—or some variation—dozens of times. Your patients are bombarded with testimonials, before-and-after photos, and influencer endorsements claiming ketogenic diets are the answer to PCOS. Meanwhile, you’re left wondering: What does the actual science say?
A comprehensive scoping review published in September 2025 in the journal Nutrients provides some clarity. Researchers from George Fox University analyzed eight clinical studies involving women with PCOS who adopted various ketogenic protocols, ranging from 45 days to 12 weeks.
The findings are compelling—but they also come with crucial caveats every clinician needs to understand before counseling patients.
Let me walk you through what this research really shows, what it means for your practice, and most importantly, what your patients need to know.
The PCOS-Insulin Resistance Connection: A Quick Refresher
Before diving into the ketogenic data, let’s revisit why metabolic interventions matter so much in PCOS.
PCOS affects approximately 7% of women worldwide, making it the most common endocrinopathy in females of reproductive age. Using the Rotterdam criteria, diagnosis requires at least two of three features:
Clinical or biochemical hyperandrogenism (elevated androgens, acne, hirsutism, alopecia)
Oligo-anovulation (cycles >35 days apart or <8 menses annually)
Polycystic ovaries on ultrasound (>12 follicles measuring 2-9mm or ovarian volume ≥10mL)
But here’s what makes PCOS particularly challenging: between 40-80% of affected women also struggle with insulin resistance and compensatory hyperinsulinemia, even when they’re not obese. This creates a vicious cycle:
Insulin resistance → Hyperinsulinemia → Ovarian androgen production ↑ → LH hypersecretion → Anovulation → Infertility
Breaking this cycle requires more than just treating symptoms—it demands metabolic intervention. Traditional advice has centered on “eat less, move more” with calorie restriction. But what if there’s a more targeted approach?
What the Research Actually Found: Eight Studies, Consistent Results
The scoping review by Fleigle and colleagues examined studies from 2019-2025, all using the Rotterdam criteria for PCOS diagnosis. Participants were overweight or obese women who adopted one of several ketogenic protocols:
The Ketogenic Protocols Tested:
Very Low-Calorie Ketogenic Diet (VLCKD): 600-800 kcal/day initially, <30g carbohydrates
Classic Ketogenic Diet (CKD): 1,300-1,500 kcal/day, <50g carbohydrates (5-10% of calories)
Mediterranean Ketogenic Diet (KEMEPHY): ~1,672 kcal/day, combining ketogenic macros with Mediterranean food principles
All protocols shared one core feature: carbohydrate restriction severe enough to induce nutritional ketosis, shifting the body’s primary fuel source from glucose to ketone bodies.
Weight Loss and Body Composition
Every single study demonstrated significant weight loss. The range: 5.6 to 18 kg (approximately 12-40 pounds) over 8-12 weeks.
But the changes went far beyond the scale:
BMI reductions: -1.91 to -17.03 kg/m²
Waist circumference: -5.44 to -10.01 cm
Body fat percentage: Significant decreases across all studies measuring this parameter
One particularly striking finding from Magagnini et al.: 76% of participants moved from an obese BMI category to overweight—a clinically meaningful shift that reduces multiple health risks.
Metabolic Improvements: Addressing the Root Cause
Here’s where the data gets interesting for those of us treating PCOS as a metabolic condition:
Insulin Sensitivity (HOMA-IR):
Improvements ranging from -0.46 to -5.70 points
Most studies showed HOMA-IR dropping below 2.5 (the threshold for insulin resistance)
One study reported 96% of participants achieving HOMA-IR <2.5
Fasting Glucose:
Decreases of -0.46 to -0.81 mmol/L (-8.28 to -14.58 mg/dL)
Achieved without pharmacologic intervention
Lipid Profiles:
Total cholesterol: -0.64 mmol/L to -40 mg/dL
Triglycerides: -7.93 mg/dL to -70 mg/dL
HDL (”good cholesterol”): +10.42 to +15 mg/dL
LDL: -21.52 to -35 mg/dL
These aren’t trivial improvements—they represent meaningful cardiovascular risk reduction.
Hormonal Normalization: The Real Game-Changer
This is where ketogenic interventions appear to address PCOS at its endocrine roots:
Androgen Reduction:
Total testosterone: -6.06 to -17.88 ng/dL
Free testosterone: -0.18 to -0.40 pg/mL (or -0.18 to -0.30 ng/dL depending on units)
Androstenedione: -0.73 ng/mL
DHEAS: -0.43 µg/mL
LH/FSH Ratio Normalization:
The elevated LH/FSH ratio characteristic of PCOS decreased by -0.47 to -1.99
FSH levels increased while LH levels decreased—moving toward a more physiologic ratio
Sex Hormone Binding Globulin (SHBG):
Increased by +7.8 to +18.08 nmol/L
This matters because higher SHBG means less free (biologically active) testosterone
Anti-Müllerian Hormone (AMH):
Decreased significantly in studies measuring it
Lower AMH correlates with reduced polycystic morphology
17-alpha-hydroxyprogesterone:
Decreased by -0.36 ng/mL in one study
Important marker of adrenal androgen excess in PCOS
Fertility and Menstrual Outcomes: What Patients Really Care About
For many of your patients, this is what matters most:
